No results for ‘’
Bombay Oxygen Investments Ltd
NSE: BSE: 509470
₹19710
(2.39%)
Mon, 22 Jun 2026, 10:53 pm
Market Cap (in Cr)295.65
PE Ratio0
Dividend0.18
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
Bombay Oxygen Investments Analysis
dividend
Pros
Cons
- Bombay Oxygen Investments is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Bombay Oxygen Investments's dividends as it is not paying a notable one for India.
- Bombay Oxygen Investments is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Bombay Oxygen Investments's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Bombay Oxygen Investments's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
Pros
- Bombay Oxygen Investments is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Bombay Oxygen Investments is profitable, therefore cash runway is not a concern.
- Bombay Oxygen Investments is profitable, therefore cash runway is not a concern.
- Bombay Oxygen Investments has no debt, it does not need to be covered by operating cash flow.
- Bombay Oxygen Investments has no debt, it does not need to be covered by short term assets.
- Bombay Oxygen Investments's cash and other short term assets cover its long term commitments.
- Bombay Oxygen Investments currently has no debt however we can't compare to 5 years ago as we have no data for that period.
- Bombay Oxygen Investments has no debt, therefore coverage of interest payments is not a concern.
- Bombay Oxygen Investments has no debt.
- Low level of unsold assets.
Cons
management
Pros
- Hema's remuneration is lower than average for companies of similar size in India.
- Hema's compensation has been consistent with company performance over the past year, both up more than 20%.
- The average tenure for the Bombay Oxygen Investments management team is over 5 years, this suggests they are a seasoned and experienced team.
Cons
- The average tenure for the Bombay Oxygen Investments board of directors is less than 3 years, this suggests a new board.
misc
Pros
Cons
- Bombay Oxygen Investments is not covered by any analysts.
past
Pros
- Bombay Oxygen Investments's 1-year earnings growth exceeds its 5-year average (228.4% vs 12.8%)
- Bombay Oxygen Investments's year on year earnings growth rate has been positive over the past 5 years.
- Bombay Oxygen Investments's earnings growth has exceeded the IN Chemicals industry average in the past year (228.4% vs 9.1%).
Cons
- Bombay Oxygen Investments used its assets less efficiently than the IN Chemicals industry average last year based on Return on Assets.
- It is difficult to establish if Bombay Oxygen Investments improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- Bombay Oxygen Investments has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
Pros
- Bombay Oxygen Investments is good value based on assets compared to the IN Chemicals industry average.
Cons
- Bombay Oxygen Investments's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Bombay Oxygen Investments's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Bombay Oxygen Investments is overvalued based on earnings compared to the IN Chemicals industry average.
- Bombay Oxygen Investments is overvalued based on earnings compared to the India market.
- BSE:509470 is up 5.8% underperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:509470 is up 5.8% underperforming the market in India which returned 8% over the past month.